KATHLEEN FOLEY ROOT: Open Payments
NPI 1770640641 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,834 in 95 payments from 16 companies in 2025. Trend: 2023 $285 · 2024 $2,015 · 2025 $2,834
Food & beverage: $2,750Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $810 |
| Madrigal Pharmaceuticals | 10 | $586 |
| Janssen Biotech, Inc. | 7 | $449 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $185 |
| Ardelyx, Inc. | 7 | $160 |
| PFIZER INC. | 2 | $138 |
| Lilly USA, LLC | 9 | $134 |
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| Ipsen Biopharmaceuticals, Inc | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, CREON, XIFAXAN, SKYRIZI, IBSRELA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
